Aardvark Therapeutics, Inc.

NasdaqGS:AARD Stock Report

Market Cap: US$270.0m

Aardvark Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:AARD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Sep 25BuyUS$96,624Tien-Li LeeIndividual10,000US$9.94
12 Sep 25BuyUS$160,654Tien-Li LeeIndividual20,000US$8.50
09 Sep 25BuyUS$48,440Nelson SunIndividual6,000US$8.07
14 Feb 25BuyUS$160,000Nelson SunIndividual10,000US$16.00
14 Feb 25BuyUS$264,672Tien-Li LeeIndividual16,542US$16.00
14 Feb 25BuyUS$3,000,000Cormorant Asset Management, LPCompany187,500US$16.00
14 Feb 25BuyUS$20,000,000Decheng Capital LLCCompany1,250,000US$16.00

Insider Trading Volume

Insider Buying: AARD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AARD?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds1,359,8836.25%
Individual Insiders3,198,97114.7%
Institutions4,219,82119.4%
VC/PE Firms6,101,56528%
General Public6,893,03231.7%

Dilution of Shares: AARD only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 67.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18%
Decheng Capital LLC
3,917,299US$48.6m0%6.24%
10%
Vickers Venture Partners
2,184,266US$27.1m0%100.0%
7.09%
Tien-Li Lee
1,544,613US$19.2m0.08%no data
6.77%
Wu Lee Jane
1,474,028US$18.3m0%no data
6.25%
Citadel Advisors LLC
1,359,883US$16.9m5.93%0.01%
4.82%
Laurion Capital Management LP
1,049,721US$13.0m6.13%1.69%
2.55%
The Vanguard Group, Inc.
555,721US$6.9m20.6%no data
1.61%
Adage Capital Management, L.P.
350,000US$4.3m100%0.01%
1.47%
Millennium Management LLC
319,623US$4.0m0%no data
1.42%
BlackRock, Inc.
309,465US$3.8m50.4%no data
1.41%
Silverarc Capital Management, LLC
306,912US$3.8m7.01%0.42%
1.17%
Schonfeld Strategic Advisors LLC
253,752US$3.1m-9.13%0.02%
0.89%
Geode Capital Management, LLC
194,035US$2.4m41.7%no data
0.67%
Cresset Asset Management, LLC
146,783US$1.8m0%0.01%
0.48%
Nelson Sun
105,484US$1.3m6.03%no data
0.44%
Cantor Fitzgerald Asset Management
96,682US$1.2m26.1%0.01%
0.43%
State Street Global Advisors, Inc.
93,005US$1.2m149%no data
0.31%
Morgan Stanley
68,462US$848.9k664%no data
0.29%
Two Sigma Investments, LP
63,569US$788.3k0%no data
0.26%
Northern Trust Global Investments
57,197US$709.2k26.9%no data
0.26%
BNP Paribas Financial Markets SNC
56,546US$701.2k59.3%no data
0.25%
UBS Asset Management AG
54,728US$678.6k5.4%no data
0.19%
Kenneth Griffin
40,596US$503.4k0%no data
0.18%
Barclays PLC
39,592US$490.9k273%no data
0.15%
Seng Chin Tan
33,000US$409.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/05 23:17
End of Day Share Price 2025/12/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aardvark Therapeutics, Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Timothy AndersonBofA Global Research
Suranjit MukherjeeBTIG
Joshua SchimmerCantor Fitzgerald & Co.